The combined incretin effect results in improved insulin sensitivity, reduced inflammation in adipose tissue, decreased hepatic glucose production, and meaningful weight loss outcomes
Key findings include HbA1c reductions of 1.87-2.07% in treatment-naive T2D (SURPASS-1
She evaluates weight changes, appetite, treatment tolerance, lifestyle progress, and overall health before determining whether adjustments are appropriate
This advanced technology helps track progress, set goals, and optimize your skincare journey with unparalleled accuracy
Current use for any purpose involves accepting that the medication remains investigational
They are not FDA-approved products